S
Signifier Medical Technologies
Improving quality of life, sleep, and relationships by tackling the root cause of snoring and sleep disordered breathing
About Signifier Medical Technologies
Signifier Medical Technologies, established in 2015, is a medical technology firm concentrating on non-invasive treatments for sleep-disordered breathing and snoring. The company was co-founded by CEO Akhil Tripathi, a serial entrepreneur in the MedTech sector, and Professor Anshul Sama, an ENT surgeon with over two decades of experience in sleep-disordered breathing. Tripathi's background in developing novel medical devices, including a robotic navigation system for neurosurgery, shaped his mission to address the root causes of sleep disorders rather than just managing symptoms. The company operates on a direct-to-consumer and business-to-business model, selling its flagship product to patients and collaborating with healthcare providers and distributors. Since its inception, Signifier has raised $57.1 million over seven funding rounds, with key investors including Segulah Medical Acceleration, The Pritzker Organization, and Waha Capital.
The company's core product, eXciteOSA®, is the first and only FDA-authorized daytime therapy for mild obstructive sleep apnea (OSA) and snoring. This prescription device utilizes neuromuscular electrical stimulation (NMES) through a silicone mouthpiece to strengthen the genioglossus (tongue) muscle. By exercising the tongue for 20 minutes daily, the therapy improves muscle endurance, preventing the tongue from collapsing backward and obstructing the airway during sleep. This approach targets a primary physiological cause of mild OSA and snoring, offering an alternative to nocturnal devices like CPAP machines. The system includes a mobile app for users to control therapy sessions, track progress, and connect with clinicians for remote monitoring. Clinical studies have demonstrated the device's effectiveness, showing significant reductions in the Apnea-Hypopnea Index (AHI), snoring time, and daytime sleepiness, with real-world data indicating a high patient adherence rate of over 80%.
A significant milestone was achieved in February 2021 when eXciteOSA® received FDA authorization, paving the way for its commercial launch in the United States. By March 2023, the therapy had been used by over 10,000 patients. Another key achievement occurred in June 2024, when Signifier secured its largest commercial order of 10,000 eXciteOSA® units from Spectrum Sleep Solutions, a major home medical equipment provider. This followed the recent approval for Medicaid coverage in South Carolina, expanding patient access to the treatment. The company has offices in London, UK, and Needham, Massachusetts, USA, to support its commercialization efforts.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 77.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Remote Monitoring, Sleeping, Wearable, Tech for Patients, Hard Tech, Digital Care, remote health monitoring, uk is8 life sciences
- Business model
- Manufacturing
- Client focus
- B2C
News
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Signifier Medical Technologies is 2.1K monthly website visits, up 16.7% over the last three months. Signifier Medical Technologies's team grew 7.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
ElvieConnected health devices for pelvic floor and breastfeeding. |
Bristol, United Kingdom | Acquired | 112 | $157M | — |
BiovotionWearable physiology monitoring company |
London, United Kingdom | Acquired | |||
Waire HealthAI-powered remote patient monitoring sensor technology |
London, United Kingdom | Operational | |||
Afon TechnologyPatented a real-time, non-invasive blood glucose monitor with the aim of benefiting millions of diabetes sufferers the world over |
Caldicot, United Kingdom | Operational | |||
PneumoWaveWearable biosensor platform for remote respiratory monitoring |
Edinburgh, United Kingdom | Operational | |||
AcurableWearable acoustic sensors for automated respiratory condition diagnosis |
London, United Kingdom | Operational | |||
SunriseAt-home sleep apnea diagnostics and virtual treatment |
City of Brussels, Belgium | Operational | |||
SteadySenseIntelligent temperature measuring systems for use in healthcare and medical sectors |
Seiersberg-Pirka, Austria | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Signifier Medical Technologies in the London ecosystem
The Signifier Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- RPRobert Parkinson
The Pritzker Organization
Series B and later6 investors entered at this stage
- AHAlan Howard
- JBJames Blair
- KGKieran Gallahue
- ANAngeluscapital
Segulah Medical- PPPioneer Healthcare Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Signifier Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Signifier Medical Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










